SNDX — Syndax Pharmaceuticals, Inc.
7 mentions in the last 24 hours · 0.03% of all mentions
Why people talked about SNDX (2026-11-03)
- Syndax Pharmaceuticals reported Q3 2026 financial results, with revenue of $83.3M beating estimates.
- The company reported an EPS of -$0.55, missing the -$0.49 estimate by 12.2%.
- Financial results were announced via a press release and Form 8-K filing on November 2, 2026.
| Bluesky | 3 | community |
| GDELT | 1 | news |
| Marketaux | 1 | news |
| RSS Bundle | 1 | news |
| SEC EDGAR 8-K | 1 | filings |